BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31400035)

  • 1. Systematic assessment of multi-echo dynamic susceptibility contrast MRI using a digital reference object.
    Stokes AM; Semmineh NB; Nespodzany A; Bell LC; Quarles CC
    Magn Reson Med; 2020 Jan; 83(1):109-123. PubMed ID: 31400035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of single bolus, dual-echo dynamic susceptibility contrast MRI protocols in brain tumor patients.
    Stokes AM; Bergamino M; Alhilali L; Hu LS; Karis JP; Baxter LC; Bell LC; Quarles CC
    J Cereb Blood Flow Metab; 2021 Dec; 41(12):3378-3390. PubMed ID: 34415211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Acquisition and Analysis Methods for Clinical Dynamic Susceptibility Contrast MRI Using a Population-Based Digital Reference Object.
    Semmineh NB; Bell LC; Stokes AM; Hu LS; Boxerman JL; Quarles CC
    AJNR Am J Neuroradiol; 2018 Nov; 39(11):1981-1988. PubMed ID: 30309842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.
    Paulson ES; Schmainda KM
    Radiology; 2008 Nov; 249(2):601-13. PubMed ID: 18780827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dynamic susceptibility contrast MRI digital reference object for testing software with leakage correction: Effect of background simulation.
    Chen HS; Jen ML; Hou P; Stafford RJ; Liu HL
    Med Phys; 2021 Oct; 48(10):6051-6059. PubMed ID: 34293208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of single-dose, dual-echo based CBV threshold for fractional tumor burden mapping in recurrent glioblastoma.
    Anil A; Stokes AM; Chao R; Hu LS; Alhilali L; Karis JP; Bell LC; Quarles CC
    Front Oncol; 2023; 13():1046629. PubMed ID: 36733305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
    Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
    AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of EPI-based distortion correction of dynamic susceptibility contrast MRI on cerebral blood volume estimation in patients with glioblastoma.
    Hovden IT; Geier OM; Digernes I; Fuster-Garcia E; Løvland G; Vik-Mo E; Meling TR; Emblem KE
    Eur J Radiol; 2020 Nov; 132():109278. PubMed ID: 33010685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas.
    Leu K; Boxerman JL; Ellingson BM
    AJNR Am J Neuroradiol; 2017 Mar; 38(3):478-484. PubMed ID: 28034995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low-Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors.
    Schmainda KM; Prah MA; Hu LS; Quarles CC; Semmineh N; Rand SD; Connelly JM; Anderies B; Zhou Y; Liu Y; Logan B; Stokes A; Baird G; Boxerman JL
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):626-633. PubMed ID: 30923088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consistency of normalized cerebral blood volume values in glioblastoma using different leakage correction algorithms on dynamic susceptibility contrast magnetic resonance imaging data without and with preload.
    Hedderich D; Kluge A; Pyka T; Zimmer C; Kirschke JS; Wiestler B; Preibisch C
    J Neuroradiol; 2019 Feb; 46(1):44-51. PubMed ID: 29753641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating Multisite rCBV Consistency from DSC-MRI Imaging Protocols and Postprocessing Software Across the NCI Quantitative Imaging Network Sites Using a Digital Reference Object (DRO).
    Bell LC; Semmineh N; An H; Eldeniz C; Wahl R; Schmainda KM; Prah MA; Erickson BJ; Korfiatis P; Wu C; Sorace AG; Yankeelov TE; Rutledge N; Chenevert TL; Malyarenko D; Liu Y; Brenner A; Hu LS; Zhou Y; Boxerman JL; Yen YF; Kalpathy-Cramer J; Beers AL; Muzi M; Madhuranthakam AJ; Pinho M; Johnson B; Quarles CC
    Tomography; 2019 Mar; 5(1):110-117. PubMed ID: 30854448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab.
    Leu K; Boxerman JL; Lai A; Nghiemphu PL; Pope WB; Cloughesy TF; Ellingson BM
    J Magn Reson Imaging; 2016 Nov; 44(5):1229-1237. PubMed ID: 26971534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of three leakage-correction methods for DSC-based measurement of relative cerebral blood volume with respect to heterogeneity in human gliomas.
    Kluge A; Lukas M; Toth V; Pyka T; Zimmer C; Preibisch C
    Magn Reson Imaging; 2016 May; 34(4):410-21. PubMed ID: 26708034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
    She D; Xing Z; Cao D
    J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol.
    Gahramanov S; Muldoon LL; Li X; Neuwelt EA
    Radiology; 2011 Dec; 261(3):796-804. PubMed ID: 21940504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
    Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard.
    Stokes AM; Semmineh N; Quarles CC
    Magn Reson Med; 2016 Aug; 76(2):613-25. PubMed ID: 26362714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic generation of DSC-MRI-derived relative CBV maps from DCE MRI of brain tumors.
    Sanders JW; Chen HS; Johnson JM; Schomer DF; Jimenez JE; Ma J; Liu HL
    Magn Reson Med; 2021 Jan; 85(1):469-479. PubMed ID: 32726488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.